Effect of the Factor V Leiden mutation on the severity of meningococcal disease

Pediatric Infectious Disease Journal

Volumn 18, Issue 10, 1999, Pages 893-896

  Kondaveeti, Sheila ^a   Hibberd, Martin L ^a   Booy, Robert ^b   Nadel, Simon ^a   Levin, Michael ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Activated protein C resistance; Factor V Leiden; Genetic susceptibility; Meningococcal disease; Protein C; Purpura fulminans

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FULMINATING PURPURA; GENE MUTATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR;

CHILD; DISSEMINATED INTRAVASCULAR COAGULATION; FACTOR V; GENOTYPE; HETEROZYGOTE; HUMANS; MENINGOCOCCAL INFECTIONS; MUTATION; PURPURA, SCHOENLEIN-HENOCH; RISK FACTORS;

EID: 0032829994     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199910000-00011     Document Type: Article

References (23)

1. Adcock DM, Hicks MJ. Dermatopathology of skin necrosis associated with purpura fulminans. Semin Thromb Hemost 1990;16:283-92.
2. Powars D, Larsen R, Johnson J, et al. Epidemic meningococcemia and purpura fulminans with induced protein C deficiency. Clin Infect Dis 1993;17:254-61.
3. Lammle B, Tran TH, Ritz R, Duckert F. Plasma prekallikrein, Factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC). Am J Clin Pathol 1984;82:396-404.
4. Leclerc F, Hazelzet J, Jude B, et al. Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases. Intensive Care Med 1992;18:4:202-5.
5. Levin M, Eley BS, Louis J, Cohen H, Young L, Heyderman RS. Postinfectious purpura fulminans caused by an autoantibody directed against protein S. J Pediatr 1995;127:355-63.
6. Gomez E, Ledford MR, Pegelow CH, Reitsma PH, Bertina RM. Homozygous protein S deficiency due to a one base pair deletion that leads to a stop codon in exon III of the protein S gene. Thromb Haemost 1994;71:6:723-6.
7. Marciniak E, Wilson HD, Marlar RA. Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood. Blood 1985;65:1:15-20.
8. Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993;82:1989-93.
9. Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994;330: 566-7.
10. Rees DC, Cox M, Clegg JB. World distribution of Factor V Leiden. Lancet 1995;346:1430.
11. Bertina RM, Koeleman BP, Koster T. Mutation in blood coagulation Factor V associated with resistance to activated protein C. Nature 1994;369:14-5.
12. Zoller B, Dahlback B. Linkage between inherited resistance to activated protein C and Factor V gene mutation in venous thrombosis. Lancet 1994;343:1515-6.
13. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of Factor V Leiden mutation. Lancet 1994;344:1453-7.
14. Bridey F, Wolff M, Laissy JP, Morin V, Lefebvre M, de-Prost D. Fatal cerebral venous sinus thrombosis associated with the Factor V Leiden mutation and the use of oral contraceptives. Thromb Haemost 1995;74:1382.
15. Ganesan V, Kelsey H, Cookson J, Osborn A, Kirkham FJ. Activated protein C resistance in childhood stroke. Lancet 1996;347:260.
16. Simioni P, de-Ronde H, Prandoni P, Saladini M, Bertina RM, Girolami A. Ischemic stroke in young patients with activated protein C resistance: a report of three cases belonging to three different kindreds. Stroke 1995;26:885-90.
17. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation Factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912-7.
18. Petaja J, Jalanko H, Holmberg C, Kinnunen S, Syrjala M. Resistance to activated protein C as an underlying cause of recurrent venous thrombosis during relapsing nephrotic syndrome. J Pediatr 1995;127:103-5.
19. Pipe SW, Schmaier AH, Nichols WC, Ginsburg D, Bozynski ME, Castle VP. Neonatal purpura fulminans in association with Factor V R506Q mutation. J Pediatr 1996;128:706-9.
20. Balakrishnan G, Aitchison T, Hallworth D, Morton NS. Prospective evaluation of the Paediatric Risk of Mortality (PRISM) score. Arch Dis Child 1992;67:196-200.
21. Sackesen C, Secmeer G, Gurgey A, et al. Homozygous Factor V Leiden mutation in a child with meningococcal purpura fulminans. Pediatr Infect Dis J 1998;17:87.
22. Osterud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost 1983;49:5-7.
23. Kornelisse RF, Hazelzet JA, Savelkoul HF, et al. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J Infect Dis 1996;173: 5:1148-56.